GOVERNMENT SPEAKERS INCLUDE
Speaker

Julia Tierney

Chief of Staff
Food and Drug Administration (FDA)

Speaker

Anne Gussow

Supervisory Patent Examiner, Quality Assurance Specialist
USPTO

Speaker

Karlheinz Skowronek

Supervisory Patent Examiner, Bioinformatics
USPTO

Speaker

Julie Wu

Supervisory Patent Examiner, Immunotherapy and Recombinant Antibodies
USPTO

Be part of the discussions that will shape and transform the future of therapeutics

mRNA, CRISPR, CAR T – all acronyms for emerging and novel therapeutics that are changing modern medicine as we know it. However, the complexities concerning ownership, funding, and tech strategies for these next generation therapeutic modalities and gene therapies are the greatest barriers to commercialization.

ACI has created The National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies to provide you with solutions to some of the greatest challenges impeding market access for these products.

We are pleased to announce that representatives from the USPTO and FDA, as well as, distinguished in-house and outside counsel, will present at this groundbreaking event to discuss IP and regulatory initiatives that are essential to the proliferation of these therapeutics.

 

CLE Accreditation

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.

Worry Free
Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE

Register at the preferred early rate with our worry free cancellation guarantee.

Learn More
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image